Log in to save to my catalogue

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1056_NEJMoa1504720

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

About this item

Full title

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Journal title

The New England journal of medicine, 2015-11, Vol.373 (22), p.2117-2128

Language

English

Formats

More information

Alternative Titles

Full title

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_citationtrail_10_1056_NEJMoa1504720

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1056_NEJMoa1504720

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1504720

How to access this item